| Title : Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil - Ortner_2020_Drug.Des.Devel.Ther_14_3251 |
| Author(s) : Ortner M , Stange M , Schneider H , Schroder C , Buerger K , Muller C , Muller-Sarnowski F , Diehl-Schmid J , Forstl H , Grimmer T , Steimer W |
| Ref : Drug Des Devel Ther , 14 :3251 , 2020 |
| Abstract : Ortner_2020_Drug.Des.Devel.Ther_14_3251 |
| ESTHER : Ortner_2020_Drug.Des.Devel.Ther_14_3251 |
| PubMedSearch : Ortner_2020_Drug.Des.Devel.Ther_14_3251 |
| PubMedID: 32848364 |
Ortner M, Stange M, Schneider H, Schroder C, Buerger K, Muller C, Muller-Sarnowski F, Diehl-Schmid J, Forstl H, Grimmer T, Steimer W (2020)
Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil
Drug Des Devel Ther
14 :3251
Ortner M, Stange M, Schneider H, Schroder C, Buerger K, Muller C, Muller-Sarnowski F, Diehl-Schmid J, Forstl H, Grimmer T, Steimer W (2020)
Drug Des Devel Ther
14 :3251